Alexandre Lebeaut
Chief Scientific Officer & Vice president
R&D
Ipsen
France
Biography
Dr. Alexandre Lebeaut joined Ipsen in 2013 as Senior Vice President, Chief Development Officer, Global Drug Development and was appointed Interim Head of R&D in December 2016. Dr. Lebeaut earned his M.D. from Paris Diderot University and specialized in Pediatrics from Paris Descartes University. Before joining Ipsen, he held several global leadership positions in Clinical Development and Medical Affairs with biopharmaceutical companies including Axcan Pharmaceuticals, Sanofi, Novartis and Schering Plough Research Institute.
Research Interest
Research interest is mainly in development of clinial, pediatric drugs in improved and developed quality.